Practice
Featured experience
Big Lots chapter 11 filing, $707.5 million DIP financing and stalking horse APA
We are advising Big Lots in connection with the restructuring
VF $1.5 billion sale of Supreme to EssilorLuxottica
We are advising VF on the transaction
Truist $15.5 billion sale of remaining stake in Truist Insurance to investor group
We are advising Truist on the transaction
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
REV Group $127.5 million secondary offering
We advised REV Group on its SEC-registered secondary stock offering
Trial Holdings ¥44.6 billion IPO
The shares are listed on the Tokyo Stock Exchange
Crane NXT $270 million acquisition of OpSec Security
We are advising Crane NXT on the acquisition
Rubicon closes approximately $1.18B fundraise for second flagship PE fund
We advised Rubicon on the fundraise
SMFG $1 billion perpetual subordinated notes offering
We advised SMFG on its SEC-registered offering of Additional Tier 1 notes
TruArc Partners acquisition of Meyer Laboratory and $179 million financing
We advised TruArc Partners on the acquisition and related financing arrangements
SEB $1.75 billion notes offering
The investment-grade notes are due 2027 and 2029
Lightyear Capital strategic investment in Prime Pensions
We advised Lightyear Capital on the transaction and related debt financing
REV Group $289.9 million secondary offering
We advised REV Group on its SEC-registered secondary stock offering
Delinea acquisition of Fastpath Solutions
We are advising Delinea on the acquisition